Vaxcyte, Inc. (PCVX)
71.38
+6.36
(+9.79%)
USD |
NASDAQ |
Oct 09, 16:00
71.27
-0.11
(-0.15%)
After-Hours: 20:00
Vaxcyte Free Cash Flow : -921.07M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -921.07M |
| March 31, 2026 | -814.94M |
| December 31, 2025 | -712.55M |
| September 30, 2025 | -620.72M |
| June 30, 2025 | -564.16M |
| March 31, 2025 | -600.01M |
| December 31, 2024 | -571.79M |
| September 30, 2024 | -616.24M |
| June 30, 2024 | -582.34M |
| March 31, 2024 | -476.17M |
| December 31, 2023 | -364.67M |
| September 30, 2023 | -245.16M |
| June 30, 2023 | -219.66M |
| March 31, 2023 | -199.12M |
| Date | Value |
|---|---|
| December 31, 2022 | -176.44M |
| September 30, 2022 | -162.55M |
| June 30, 2022 | -153.30M |
| March 31, 2022 | -144.12M |
| December 31, 2021 | -127.95M |
| September 30, 2021 | -86.96M |
| June 30, 2021 | -69.91M |
| March 31, 2021 | -48.15M |
| December 31, 2020 | -47.78M |
| September 30, 2020 | -52.75M |
| June 30, 2020 | -49.18M |
| March 31, 2020 | -53.74M |
| December 31, 2019 | -49.44M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Moderna, Inc. | -1.244B |
| Vir Biotechnology, Inc. | -203.59M |
| Revolution Medicines, Inc. | -1.232B |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -232.47M |
| Cash from Investing (Quarterly) | 147.72M |
| Cash from Financing (Quarterly) | 5.701M |
| Free Cash Flow Per Share (Quarterly) | -1.640 |
| Free Cash Flow to Equity (Quarterly) | -236.19M |
| Free Cash Flow to Firm (Quarterly) | -237.04M |
| Free Cash Flow Yield | -9.36% |